Oppenheimer & Co. Inc. Has $4.84 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Oppenheimer & Co. Inc. boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 201.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,111 shares of the biotechnology company’s stock after buying an additional 8,097 shares during the period. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $4,840,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Empowered Funds LLC bought a new stake in Axon Enterprise in the first quarter valued at about $340,000. Concurrent Investment Advisors LLC acquired a new position in shares of Axon Enterprise in the 1st quarter worth approximately $216,000. Russell Investments Group Ltd. lifted its position in shares of Axon Enterprise by 18.9% during the 1st quarter. Russell Investments Group Ltd. now owns 62,466 shares of the biotechnology company’s stock worth $19,572,000 after buying an additional 9,925 shares during the period. Avantax Advisory Services Inc. boosted its stake in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after buying an additional 40 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Axon Enterprise by 15.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 82,347 shares of the biotechnology company’s stock valued at $25,765,000 after acquiring an additional 10,718 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 411,006 shares of company stock worth $161,360,618. Company insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of analyst reports. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Craig Hallum boosted their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, JMP Securities increased their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Trading Up 0.5 %

Shares of AXON opened at $604.56 on Friday. The stock’s fifty day simple moving average is $433.89 and its 200-day simple moving average is $355.28. The firm has a market capitalization of $46.10 billion, a PE ratio of 156.22, a price-to-earnings-growth ratio of 15.10 and a beta of 0.94. Axon Enterprise, Inc. has a 12-month low of $220.77 and a 12-month high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.